Isabelle M. Rosso

Dr. Isabelle M. Rosso

Department of Psychiatry, Harvard Medical School, Center for Depression, Anxiety, and Stress Re-search, McLean Hospital, Belmont, MA 02478, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2005 in Biological Psychiatry
Verified
Journal Article
Closed access
Isabelle M. RossoIsabelle M. Rosso
Isabelle M. Rosso
CCChristina M. Cintron
Christina M. Cintron
RSRonald J. Steingard
Ronald J. Steingard
PRPerry F. Renshaw
Perry F. Renshaw
AYAshley D. Young
Ashley D. Young
DYDeborah A. Yurgelun-Todd
Deborah A. Yurgelun-Todd

16 July 2013 in Depression and Anxiety
Verified
Journal Article
Closed access
PDF file
Isabelle M. RossoIsabelle M. Rosso
Isabelle M. Rosso
MWMelissa R. Weiner
Melissa R. Weiner
DCDavid J. Crowley
David J. Crowley
MSMarisa M. Silveri
Marisa M. Silveri
SRScott L. Rauch
Scott L. Rauch
JJJ. Eric Jensen
J. Eric Jensen
Background Increased reactivity of the insular cortex and decreased activity of the dorsal anterior cingulate cortex (ACC) are seen in functional imaging studies of posttraumatic stress disorder (PTSD), and may partly explain the persistent fear and anxiety proneness that characterize the disorder. A possible neurochemical correlate is altered function of the inhibitory neurotransmitter gamma‐aminobutyric acid (GABA). We report results from what we believe is the first study applying proton magnetic resonance spectroscopy (1H‐MRS) to measure brain GABA in PTSD. Methods Thirteen adults with DSM‐IV PTSD and 13 matched healthy control subjects underwent single voxel 1H‐MRS at 4 Tesla. GABA was measured in the right anterior insula and dorsal ACC, using Mescher‐Garwood Point‐Resolved Echo Spectroscopy Sequence (MEGAPRESS) spectral editing. Subjects were interviewed with the Structured Clinical Interview for DSM‐IV and the Clinician Administered PTSD Scale, and also completed the State and Trait Anxiety Inventory. Results Insula GABA was significantly lower in PTSD subjects than in controls, and dorsal ACC GABA did not differ significantly between the groups. Insula GABA was not significantly associated with severity of PTSD symptoms. However, lower insula GABA was associated with significantly higher state and trait anxiety in the subject sample as a whole. Conclusions PTSD is associated with reduced GABA in the right anterior insula. This preliminary evidence of the 1H‐MRS GABA metabolite as a possible biomarker of PTSD encourages replication in larger samples and examination of relations with symptom dimensions. Future studies also should examine whether insula GABA is a marker of anxiety proneness, cutting across clinical diagnostic categories.

1 March 2007 in Biological Psychiatry
Verified
Journal Article
Closed access
Isabelle M. RossoIsabelle M. Rosso
Isabelle M. Rosso
WKWilliam D. S. Killgore
William D. S. Killgore
CCChristina M. Cintron
Christina M. Cintron
SGStaci A. Gruber
Staci A. Gruber
MTMauricio Tohen
Mauricio Tohen
DYDeborah A. Yurgelun-Todd
Deborah A. Yurgelun-Todd

1 June 2004 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
Isabelle M. RossoIsabelle M. Rosso
Isabelle M. Rosso
AYAshley D. Young
Ashley D. Young
LFLisa A. Femia
Lisa A. Femia
DYDeborah A. Yurgelun‐Todd
Deborah A. Yurgelun‐Todd

13 February 2017 in Neuropsychopharmacology
Verified
Journal Article
Closed access
Isabelle M. RossoIsabelle M. Rosso
Isabelle M. Rosso
DCDavid J Crowley
David J Crowley
MSMarisa M Silveri
Marisa M Silveri
SRScott L Rauch
Scott L Rauch
JJJ Eric Jensen
J Eric Jensen

14 December 2021 in Brain and Behavior
Verified
Journal Article
Open access
PDF file
ACAshley Clausen
Ashley Clausen
KFKelene A. Fercho
Kelene A. Fercho
MMMolly Monsour
Molly Monsour
SDSeth Disner
Seth Disner
LSLauren Salminen
Lauren Salminen
RMRajendra A. Morey
Rajendra A. Morey
Background: Posttraumatic stress disorder (PTSD) is associated with markers of accelerated aging. Estimates of brain age, compared to chronological age, may clarify the effects of PTSD on the brain and may inform treatment approaches targeting the neurobiology of aging in the context of PTSD.Method: Adult subjects (N = 2229; 56.2% male) aged 18–69 years (mean = 35.6, SD = 11.0) from 21 ENIGMA‐PGC PTSD sites underwent T1‐weighted brain structural magnetic resonance imaging, and PTSD assessment (PTSD+, n = 884). Previously trained voxel‐wise (brainageR) and region‐of‐interest (BARACUS and PHOTON) machine learning pipelines were compared in a subset of control subjects (n = 386). Linear mixed effects models were conducted in the full sample (those with and without PTSD) to examine the effect of PTSD on brain predicted age difference (brain PAD; brain age − chronological age) controlling for chronological age, sex, and scan site.Results: BrainageR most accurately predicted brain age in a subset (n = 386) of controls (brainageR: ICC = 0.71, R = 0.72, MAE = 5.68; PHOTON: ICC = 0.61, R = 0.62, MAE = 6.37; BARACUS: ICC = 0.47, R = 0.64, MAE = 8.80). Using brainageR, a three‐way interaction revealed that young males with PTSD exhibited higher brain PAD relative to male controls in young and old age groups; old males with PTSD exhibited lower brain PAD compared to male controls of all ages.Discussion: Differential impact of PTSD on brain PAD in younger versus older males may indicate a critical window when PTSD impacts brain aging, followed by age‐related brain changes that are consonant with individuals without PTSD. Future longitudinal research is warranted to understand how PTSD impacts brain aging across the lifespan.